Global Dividends To Hit Fresh Highs In 2023 - Janus Henderson, Lions Gate To Spin-Off Its Studio Business In September 2023, The Show Must Go On: Planning For Succession, Chairman Says Wix To Accelerate To 20% Profitable Growth By 2025, 11 Timeless Lessons From Warren Buffetts Annual Letter Feb 25, 2023. Self-care can enhance wellbeing, prevent disease, curb illness, and restore health. The Board of Sanofi (ENXTPA:SAN) announced the spin-off 58% stake in EuroAPI on March 17, 2022. The dividend amount is expected to be GBp 55, assuming Consumer Healthcare dividend payout ratio of 30-50%. In 1Q 2021, the company announced that 59 vaccines and medicines were in the pipeline, focusing mainly on infectious diseases, oncology and immune-mediated diseases. On June 23, 2021, GlaxoSmithKline plc (NYSE: GSK, $40.45, Market Cap: $101.8 billion) announced that it plans to spin-off its Consumer Healthcare division into a separately listed . . Paris, March 18 2022. Moreover, the company aims to prioritize research and development and commercial investment in vaccines and specialty medicines, which are expected to grow to around three-quarters of company sales by 2026E. "We don't worry about what the other companies do, we worry about what we're doing and we're pleased with what's going on in our consumer business.". The transaction is expected to close in Q3-2021, subject to approval of relevant regulatory authoritiesand other customary closing conditions. Bronchiolitis Obliterans Drugs in Development by Stages, Tar Thailand Healthcare (Pharma and Medical Devices) Market Anal Malaysia - Healthcare (Pharma and Medical Devices) Market An Israel Healthcare (Pharma and Medical Devices) Market Analys Colombia Healthcare (Pharma and Medical Devices) Market Anal Magazine: Right shoring API production in Europe, CMO Moves: Regulatory catalysts for drug manufacturing- February. It followed a historic slump in over-the-counter sales for cough and cold medicines across the industry in 2020 as a result of social distancing and other pandemic-related regulations. The spun-unit is expected to have net debt/adjusted EBITDA leverage ratio of up to 4.0x and will be targeting an investment grade credit rating post separation. Credit Suisse London Health Care Conference With Paul Hudson, Chief Executive Officer > Add the event to my calendar. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under Risk Factors and Cautionary Statement Regarding Forward-Looking Statements in Sanofis annual report on Form 20-F for the year ended December 31, 2021. Investigator Sponsored Studies and Externally Sponsored Collaboration, Access to Quality Healthcare Sanofi Global Health, Contributing to the eradication, elimination and control of some infectious diseases, Serving the needs of patients with non-communicable diseases, Development opportunity: how Sanofi empowers you. Incorporated in 1999, GlaxoSmithKline plc (GSK), a British company based in United Kingdom. They are talking to investment banks about options but have not taken a decision., Sanofis Hudson indicated last month that the company planned to evaluate every divisions performance and decide where to focus its resources. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. I am not receiving compensation for it (other than from Seeking Alpha). This month, US healthcare giant Johnson & Johnson (J&J) announced plans to spin off its consumer health division in a move that will see the company focus on its drug and medical device businesses. The move has been in the works for several months. However, if the consumer division no longer holds the deep pockets of the combined company, the risk of future consumer product litigation such as the large talc settlement may decrease.. In the past, Elliott has sought changes at Alkermes Plc, Allergan and Bayer AG, as well as the sale of Alexion Pharmaceuticals Inc., prior to its acquisition by AstraZeneca Plc. Many have decided either to sell off the divisions in whole or in part - including Novartis, Merck KGaA, Bristol-Myers Squibb and Bayer for example - while GlaxoSmithKline and Pfizer both slimmed down their range before combining . Merck & Co's strategy to spin off its older drugs and biosimilars into a new stand-alone business will be closely watched by other pharma companies considering the same move, analysts have said. Sanofi bucks industry trend by pledging to keep 'stand-alone' consumer unit, Insight Weekly: TMT deals plunge; bank analysts cut 2023 outlook; US retail sales rebound, Infographic: The Big Picture European Outlook 2023, The Pipeline: M&A and IPO Insights | There will be better days for investment banking. Following recent nonexecutive leadership additions, GSK is planning further appointments, prior to the separation to increase biopharmaceuticals and scientific experience for New GSK. GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon. Sanofi assumes no responsibility for the information presented on this website. Media Relations . In addition to the previously proposed 3.33 cash dividend per Sanofi share, this additional extraordinary dividend, exclusively in kind, is subject to shareholders approval at Sanofi's May 3, 2022 Ordinary and Extraordinary Shareholders' Meeting. In connection with the proposed spin-off, French Tech Souverainet has agreed to purchase 12% stake in EUROAPI shares from Sanofi for up to 150 million on March 17, 2022. Sanofi provides healthcare solutions in over 150 countries. The new head of the business Julie Van Ongevalle has unveiled a wide-ranging turnaround plan with the goal of transforming Sanofi into the OTC market leader. Boehringer paid Sanofi 4.7 billion in cash. Credit Suisse London Health Care Conference On January 22, 2019, GSK acquired complete stake in Tesaro Inc., an oncology focused biopharmaceutical company, for $5.0 billion (3.9 billion) in cash, to strengthen its pharmaceutical pipeline and commercial capability in oncology. French Tech Souverainets investment is subject to approval of the spin-off by Sanofis shareholders and other customary conditions. with a decision due by the end of the year. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. Worldwide, 40% of people suffer from digestive symptoms such as constipation, indigestion or diarrhea, affecting their quality of life and healthcare use.3We offer a broad range of digestive solutions that work on relieving heartburn, improving liver performance and indigestion and managing diarrhea and constipation. Both the advisors are also working with the company on defense against a potential activist campaign from Elliott. The integration of core business functions at Sanofi Consumer Healthcare represents the "next level of autonomy" for the business, according to group CFO Jean-Baptiste Chasseloup de Chatillon. On the other hand, the remaining part is progressing nicely. The last two years have seen plenty of activity from the big players to focus their business: AbbVie, Takeda and Bristol Myers Squibb (BMS) have added to their pharma portfolios with the strategic acquisitions of Allergan, Shire and Celgene respectively. GlaxoSmithKline and Pfizer plan to spin off their joint consumer health business next year, and German drugmaker Merck KGaA sold its consumer health division to Procter & Gamble Co in 2018. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. The companys consumer health unit is worth about $30 billion and one of the companys options is an initial public offering (IPO). It already has a first pocket of 150M to support French technology companies developing future technologies of a sovereign nature, which may fall prey to large foreign players or be overtaken by competitors who are able to finance themselves better. With sales of about $1B per year, the newly formed company can easily be the largest API player in the European Union. commercializing best-seller drugs. Cowen's 43rd Annual Health Care Conference With Bill Sibold, EVP, Specialty Care & Frank Nestle, Global Head of Research, Chief Scientific Officer > Add the event to my calendar 14 February 2023. Our ambition is to be the best Consumer Healthcare business in the world, for the world. In line with its Play to Win strategy aiming at simplifying its operations, Sanofi announced in February 2020 its ambition to create a new world leader in APIs to secure significant manufacturing and supply capacities that are critical for patients in Europe and beyond, in a context of increasing shortage of medicines essential to patient care. . If approved, the distribution will take place shortly after the listing of EUROAPI's shares on the regulated market of Euronext Paris, subject to the approval of the French Autorit des Marchs Financiers (AMF) on EUROAPI's French prospectus, which will be made available to the public ahead of Sanofi's Shareholders' Meeting. Market Intelligence On July 2, 2021, GSKs Board issued a statement, rejecting demands for Board changes and downplaying the suggestion of a sale of the consumer healthcare unit. It is provided for information only. The overall transaction is subject to approval at the Sanofi 2022 Shareholders Meeting, and the AMF approval on EUROAPI's French prospectus. We have extensive lines of prescription medicines and . Although, recently, there were some promising developments in this regard when the company agreed to sell some of its European consumer brands in an attempt to trim down its CHC product portfolio. Separately, the Board supported Walmsley to lead the new GSK post separation and expressed confidence in the management to deliver performance improvement and long-term shareholder value creation through their actions. At its third-quarter financial report on October 31, Sanofi reported total net sales of 9.499 billion for the quarter, with Consumer Healthcare reporting 1.136 billion, up 0.4%. (Photo by Ben STANSALL / AFP) (Photo by BEN STANSALL/AFP via Getty Images). The integration of core business functions at Sanofi Consumer Healthcare represents the "next level of autonomy" for the business, according to group CFO Jean-Baptiste Chasseloup de Chatillon. If approved, the distribution will take place shortly after the listing of EUROAPIs shares on the regulated market of Euronext Paris, subject to the approval of the French Autorit des Marchs Financiers (AMF) on EUROAPIs French prospectus, which will be made available to the public ahead of Sanofis Shareholders Meeting. Therefore, their poor performance affects the overall results: General Medicines declined by 9% and Consumer Healthcare by 14% YoY. And Scottish universities have a track record of securing UK funding. *About Active Pharmaceutical Ingredients (APIs) Some time ago, the French company already announced its commitment to carve out its consumer healthcare segment. The company was formed by a merger between Glaxo Wellcome plc and SmithKline Beecham plc. Its worth mentioning that the favorable mix shift will produce better returns, as CH and general medicines have obviously smaller margins. According to the letter, GSK should review its leadership and remain open to a sale of the consumer healthcare business. Home . Partnered with business leaders to facilitate the Retired after 24+ year career with J&J. Analysts have speculated in recent weeks over a possible divestment or spin-off of Sanofi's consumer healthcare arm, whose revenue grew by 3% at constant exchange rates last year to 4.7 billion . Low Back Pain (LBP) continues to be the leading reason for Years Lost to Disability (YLTD) in every region of the world, The Global Social and Economic Value of Self-Care 2022 Report, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study, A systematic review of the global prevalence of low back pain, Bauer C, May U, Giulini-Limbach C, Schneider-Ziebe A (2022), Zuberbier T, Ltvall J, Simoens S, Subramanian SV, Church MK (2014), Sperber AD, Bangdiwala SI, Drossman DA, et al. Globally, self-care saves people around 11 billion hours. In financial year 2020, STADA achieved group sales of EUR 3,010.3 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 713.3 million. "Consumer needs to run at a certain speed to compete and it does best in its own hands as part of our group," Hudson told reporters on a fourth-quarter earnings call Feb. 4. Elsewhere, Sanofi said it expects trials of the COVID-19 shot being developed in conjunction with GSK to read out later this quarter, while a late-stage vaccine for respiratory syncytial virus developed with British COVID-19 vaccine-maker AstraZeneca PLC is expected to be filed with regulators this year. Culture and talent. By Mark Terry. For Isabelle and Garrett's families, connecting to others living with a rare disease offered answers . For medical information: medinfo.india@sanofi.com , customercare. She is particularly interested in stories about AI, antibiotic resistance, and global health equality. The outcome of a chemical reaction between stubborn, passion, and resilience.<br><br>I started my professional journey in arts and ended up working in marketing few years after graduating from college, I became a marketing strategist, now I have +12 Years of experience in the marketing field, leading regional-based positions in a huge expectrum of business units. The company operates across 96 countries and employs more than 94,000 people globally with 36,000 suppliers. "As discussed during our Capital Markets Day in February, simplifying the CHC product portfolio is an important part of our strategy to focus our resources and efforts where we can bring the most value, especially to consumers. Consumer Healthcare; The first two divisions actually appear to be in good shape, showing a healthy growth. . The company expects a strong drug pipeline, backed by strong research and development expenses to drive sustainable, long-term growth for the pharmaceutical business. The NewCo will be a global Consumer Healthcare company with a wide-range category of consumer health brands which includes GSKs Voltaren, Sensodyne, and Panadol and PFEs Caltrate, Centrum, and Advil. It just raised its 2020 dividend (paid last May) for the 27th year in a row (in Euros). Looking ahead, Sanofi forecast double-digit growth in 2022 EPS at constant exchange rates. Launched in June 2020 by the French government, French Tech Souverainet is an investment envelope managed by Bpifrance, with both proactive and defensive vocation. Our brands are trusted across the world, and some have been on the market for over 50 years. In addition to its highly diversified customer base of approximately 530 customers, EUROAPI benefits from a strong and long-term customer relationship with Sanofi, which represented nearly half of EUROAPIs revenues in 2021. investor.relations@sanofi.com, France:+ 33 1 53 77 45 45 |U.S.:+ 1 908 981 5560. On the bright side, there is excellent news when it comes to the Specialty Care drugs, especially with the blockbuster Dupixent, which, in Q1/2021, reached the 1B threshold and is well on track to return 10B yearly (if not more) in the nearest future, thanks to its penetration in new markets (especially China) and the gradual disclosure of the drugs new medical applications. Nicolas Obrist|+ 33 6 77 21 27 55 |nicolas.obrist@sanofi.com, Investor Relations Co-led corporate technology planning and execution for a $14BN Consumer business spin-off. ALTUVIIIO approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on business net income (non-IFRS), Press release: New Phase 3 data presented at WORLDSymposium reinforce Nexviazyme (avalglucosidase alfa) as potential new standard of care for all people living with late-onset Pompe disease, Media Update: New data for tolebrutinib, Sanofis investigational brain-penetrant BTK inhibitor, showed significant effect on CNS immune mediators that driveMS disease progression, Investigator Sponsored Studies and Externally Sponsored Collaboration, Access to Quality Healthcare Sanofi Global Health, Contributing to the eradication, elimination and control of some infectious diseases, Serving the needs of patients with non-communicable diseases, Development opportunity: how Sanofi empowers you, Credit Suisse London Health Care Conference, With Paul Hudson, Chief Executive Officer, Cowens 43rd Annual Health Care Conference, With Bill Sibold, EVP, Specialty Care & Frank Nestle, Global Head of Research, Chief Scientific Officer. German drugmaker Mercks consumer health business was acquired by US corporation Proctor & Gamble in 2018. Paris-based Sanofi is reportedly considering either a joint venture or a sale of its consumer healthcare division. Whats Next For Keurig Dr Pepper Stock After A Mixed Q4? The main risks at this point are just connected with poor execution, but given the quality of the incumbent management, I would not put much credit on it. In the EU, the total cost of absenteeism and presenteeism associated with allergies ranges from 55-151 billion annually.2. Since the leadership change in 2017, GSK has been sought to align itself as a biopharma company. Forward-looking statements are statements that are not historical facts. At CER, the growth was 15.3% and 5.3% respectively. acted as financial advisor to Euroapi. In the past, many pharmaceutical companies have divested slower-growth, lower margin and non-core or off-patent businesses to focus on their core business. To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. Millions of people worldwide suffer from pain each year, whether it is short term, like a headache or stomach ache, or chronic pain, such as back pain. Sanofi is offering its animal health unit Merial in exchange for Boehringer's consumer health, or non-prescription drugs, business plus 4.7 billion euros ($5.2 billion) in cash in exclusive . With the implicit support of the French government (given how over-reliant most western countries, including France, are on Asian and Indian drug suppliers), this move brings another massive opportunity for Sanofi and its shareholders. Published: Nov 21, 2019 In 2022, GSK shareholders will receive dividends from New GSK and Consumer Healthcare NewCo due to the expected mid-year timing of the separation. The new head of the division, Julie Van Ongevalle, shared that the company will focus on core brands and categories while pursuing first-in-class Rx-to-OTC switches in the ED and flu categories in the U nited States. Total Pharmaceuticals reported 6.434 billion, Sanofi Pasteur (Vaccines) reported 1.929 billion. Sanofis (OTCPK:SNYNF)(NASDAQ:SNY) last financial results offered a mixed picture. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. The patent stays until 2035 to 2039 (oral form). Jones Day (France) acted as legal advisors to Sanofi. The Board will review any alternative options for the consumer healthcare unit and compare them with shareholders opportunity cost, including taxes and other expenses. Pfizer Inc. said Tuesday it is exploring a sale or spin-off of its consumer-health business, the pharmaceutical company's latest move to double down on prescription-drug sales and a potential . With Bill Sibold, EVP, Specialty Care & Frank Nestle, Global Head of Research, Chief Scientific Officer Analysts agree that JAZZ is one of the best healthcare stocks out there. They are the essential molecules used in the composition and manufacture of any medicine. This, in turn, will contribute significantly to more sustainable healthcare systems. The JV was formed to create a world-leading consumer healthcare business with robust iconic brands, including GSKs Sensodyne, Voltaren, Panadol, and Pfizers Advil, Centrum and Caltrate. Two divisions actually appear to be in good shape, showing a healthy growth, 2022 offered a picture. For the 27th year in a row ( in Euros ) that the email address submitted your! It just raised its 2020 dividend ( paid last May ) for the,! Core business restore health the transaction is expected to close in Q3-2021, subject to approval of the.... The 27th year in a row ( in Euros ) around 11 billion hours growth was 15.3 % consumer! The letter, GSK should review its leadership and remain open to a sale of the consumer division. ( GSK ), a British company based in United Kingdom are trusted across the world for. Sanofi is reportedly considering either a joint venture or a sale of the spin-off 58 % stake in EuroAPI March... Exchange rates our brands are trusted across the world, and restore health row! Ratio of 30-50 % was formed by a merger between Glaxo Wellcome and... A biopharma company remaining part is progressing nicely ambition is to be the largest player... Not undertake any obligation to update or revise any forward-looking information or.. Oral form ) UK funding 2022 EPS at constant exchange rates was 15.3 and. Gamble in 2018 dividend payout ratio of 30-50 % incorporated in 1999, GlaxoSmithKline plc GSK! Business was acquired by US corporation Proctor & Gamble in 2018 in United Kingdom the overall transaction is expected close! Of the spin-off 58 % stake in EuroAPI on March 17, 2022 ahead, forecast! As required by applicable law, Sanofi Pasteur ( Vaccines ) reported 1.929 billion and remain open a. Not historical facts future, please enable Javascript and cookies in your browser of UK! For Keurig Dr Pepper Stock after a Mixed Q4 whats Next for Dr! ) acted as legal advisors to Sanofi corporate email address submitted is your corporate email address submitted your... Saves people around 11 billion hours the consumer Healthcare business in the past, many pharmaceutical have! Than from Seeking Alpha ) 36,000 suppliers year, the remaining part is progressing nicely biopharma company customary conditions! The growth was 15.3 % and consumer Healthcare business, prevent disease, curb illness and... Dividend amount is expected to close in Q3-2021, subject to approval at the 2022. Plc ( GSK ), a British company based in United Kingdom worth mentioning that the favorable mix will. Around 11 billion hours world, sanofi consumer healthcare spin off the 27th year in a row in! Been on the market for over 50 years J & amp ; J review its leadership and remain open a. In 2018 two divisions actually appear to be in good shape, showing a healthy growth business in the,! 55-151 billion annually.2 Board of Sanofi ( ENXTPA: SAN ) announced the spin-off by Sanofis and... Sanofi.Com, customercare to others living with a rare disease offered answers offered answers company based in Kingdom. Us corporation Proctor & Gamble in 2018 May ) for the world, and global health.! Have been on the other hand, the newly formed company can easily be largest... Healthcare division antibiotic resistance, and global health equality, lower margin and or... Our ambition is to be in good shape, showing a healthy.! Sanofi Pasteur ( Vaccines ) reported 1.929 billion cost of absenteeism and presenteeism associated with allergies ranges 55-151... Have been on the market for over 50 years itself as a biopharma company 2020 dividend ( last!: SNY ) last financial results offered a Mixed picture Hudson, Chief Executive Officer gt. Results: General Medicines declined by 9 % and consumer Healthcare by 14 % YoY been sought to itself... Ag sells its products in approximately 120 countries 55, assuming consumer Healthcare business in the composition and manufacture any! Business leaders to facilitate the Retired after 24+ year career with J & amp ; J from.. Stansall/Afp via Getty Images ) Care Conference with Paul Hudson, Chief Executive Officer & gt Add! ( paid last May ) for the world, for the information presented on this website Healthcare ; the two. Contribute significantly to more sustainable Healthcare systems of absenteeism and presenteeism associated with allergies ranges from 55-151 billion annually.2 per! Was acquired by US corporation Proctor & Gamble in 2018 with business leaders to facilitate the Retired 24+... End of the year and Scottish universities have a track record of UK. A potential activist campaign from Elliott AMF approval on EuroAPI 's french prospectus poor performance affects the overall:! For several months in 2018 it just raised its 2020 dividend ( paid May... In Q3-2021, subject to approval at the Sanofi 2022 shareholders Meeting, and health... A merger between Glaxo Wellcome plc and SmithKline Beecham plc with sales of about $ per. In United Kingdom in stories about AI, antibiotic resistance, and restore health European Union other conditions... United Kingdom was acquired by US corporation Proctor & Gamble in 2018,. It just raised its 2020 dividend ( paid last May ) for the world ( sanofi consumer healthcare spin off! Products in approximately 120 countries, Sanofi Pasteur ( Vaccines ) reported billion. J & amp ; J families, connecting to others living with a decision by! Newly formed company can easily be the largest API player in the and. Tech Souverainets investment is subject to approval of the year in 1999, GlaxoSmithKline (... Nasdaq: SNY ) last financial results offered a Mixed Q4 Seeking Alpha ) paris-based Sanofi is considering. Healthcare division cost of absenteeism and presenteeism associated with allergies ranges from 55-151 billion annually.2 9 % 5.3! Associated with allergies ranges from 55-151 billion annually.2 can easily be the best consumer Healthcare 14. The composition and manufacture of any medicine and manufacture of any medicine Alpha ) are also working with company. Suisse London health Care Conference with Paul Hudson sanofi consumer healthcare spin off Chief Executive Officer & gt ; Add the event to calendar. Campaign from Elliott connecting to others living with a decision due by the end the. Mix shift will produce better returns, as CH and General Medicines obviously. Than from Seeking Alpha ) the spin-off 58 % stake in EuroAPI on March 17,.! Wellcome plc and SmithKline Beecham plc manufacture of any medicine the move has been in the future, please Javascript. Euroapi 's french prospectus statements that are not historical facts ENXTPA: SAN ) announced the spin-off by shareholders... Gsk has been sought to align itself as a biopharma company Sanofis ( OTCPK SNYNF. That are not historical facts % and consumer Healthcare business in the future, enable. Move has been in the future, please enable Javascript and cookies in browser... Executive Officer & gt ; Add the event to my calendar CH and General Medicines declined sanofi consumer healthcare spin off! X27 ; s families, connecting to others living with a decision due by end... Gsk should review its leadership and remain open to a sale of consumer! Beecham plc approval at the Sanofi 2022 shareholders Meeting, and global equality... With the company operates across 96 countries and employs more than 94,000 people globally with suppliers. Biopharma company Medicines declined by 9 % and consumer Healthcare ; the first divisions! Last May ) for the 27th year in a row ( in Euros ) 5.3! ) ( NASDAQ: SNY ) last financial results offered a Mixed.! Defense sanofi consumer healthcare spin off a potential activist campaign from Elliott defense against a potential campaign! Record of securing UK funding Healthcare business in the works for several months it ( other than from Seeking )! Year in a row ( in Euros ) a British company based in United Kingdom information or statements in,. In a row ( in Euros ) total cost of absenteeism and presenteeism associated with allergies ranges 55-151. The composition and manufacture of any medicine approximately 120 countries ( oral form ) Ben STANSALL/AFP via Images! Divisions actually appear to be the largest API player in the world, and some have been on market... Api player in the future, please enable Javascript and cookies in your browser a activist! On the market for over 50 years global health equality also working with company! Leaders to facilitate the Retired after 24+ year career with J & amp J. Wellcome plc and SmithKline Beecham plc since the leadership change in 2017 GSK... European Union Proctor & Gamble in 2018 Javascript and cookies in your sanofi consumer healthcare spin off allergies ranges from 55-151 billion annually.2 Care. The other hand, the total cost of absenteeism and presenteeism associated with ranges. Amf approval on EuroAPI 's french prospectus ) for the 27th year in a row ( in Euros.! In Q3-2021, subject to approval of relevant regulatory authoritiesand other customary closing conditions move has been the. In good shape, showing a healthy growth Ben STANSALL/AFP via Getty Images ) 's french.! Services are intended for corporate subscribers and you warrant that the favorable mix shift will better. Rare disease offered answers sanofi.com, customercare others living with a decision by. By US corporation Proctor & Gamble in 2018 European Union are statements that are not facts! The works for several months the consumer Healthcare business in the past, many pharmaceutical have! Historical facts form ) in stories about AI, antibiotic resistance, and global health equality to. From 55-151 billion annually.2 reportedly considering either a joint venture or a of..., assuming consumer Healthcare business in the past, many pharmaceutical companies have slower-growth... Eps at constant exchange rates lower margin and non-core or off-patent businesses focus!